Grants in Medical, Pharmaceuticals & Healthcare

The Market Access Grant Scheme (MAGS) 2026 is a Western Australian Government initiative designed to support local health and medical life sciences companies in accessing global markets. Delivered by the Department of Energy and Economic Diversification (DEED), the program provides financial assistance to help small and medium enterprises attend major national and international conferences and industry events in 2026. By subsidising travel costs, MAGS enables WA-based businesses to showcase their innovations, build strategic partnerships, attract investment, and expand their commercial reach. The scheme aligns with the WA Health and Medical Life Sciences Industry Strategy, which aims to diversify the economy, create jobs, and strengthen the state’s reputation as a global hub for health innovation.

The Collaborative Research Grant (CRG) is a competitive funding initiative co-funded by the Western Australian Government and the Defence Science and Technology Group (DSTG). It supports cross-disciplinary collaboration between WA-based industry and academic institutions to develop technologies that are relevant to Defence and aligned with national strategic priorities.

The Queensland Government is ready to work with industry on strategic partnership opportunities that will accelerate development in our priority industries – Defence, Biomedical and Biofuels.

The NSW RNA Pipeline Grants (RPG) is a $6M, single round, competitive technology development and commercialisation program supporting RNA therapeutics, vaccines, and tech development.

NSW MVP (Minimum Viable Product) Ventures Program is committed to supporting startups and innovative small and medium enterprises (SMEs) across the product lifecycle, bridging the gap between early-stage research and mature investment opportunities. The program offers grants designed to accelerate the commercialisation of highly innovative products or processes. The Program aims to: support businesses in increasing the commercialisation of innovative products and processes in NSW, and attract and retain commercialisation activities within the state. The Department of Enterprise, Investment and Trade will allocate up to $3 million annually for the Program until June 30, 2027.

The Ignite Ideas Fund offers funding for commercialising highly innovative products or services, at or beyond the minimum viable product stage. This fund serves as a companion program to the Advance Queensland Ignite Spark Program, which supports projects in advancing highly innovative products or services from prototype development through testing and validation to market readiness.

With a $20M funding pool, this initiative aims to support eligible businesses with high growth potential across advanced manufacturing, health and medical sectors, circular economy, digital technology, and agribusiness. By collaborating with commercial lenders, the fund will facilitate the establishment of loan facilities to empower innovative Victorian start-ups and scale-ups.

The Advanced Manufacturing Productivity Grant Program supports Tasmanian-based advanced manufacturing enterprises by funding productivity-enhancing activities. These include obtaining accreditations, expert advice, and developing staff and business skills, as part of the Tasmanian Government’s Advanced Manufacturing Action Plan 2028.

The South East Queensland (SEQ) Innovation Economy Fund provides grant funding to stimulate investment in capital projects that fuel the growth of innovation precincts, driving the creation of more knowledge-intensive jobs.